Last reviewed · How we verify

NCT05989919

Nasal Anatomical and Pathological Variants in Patients With Antrochoanal Polyps

Completed Last updated 18 November 2023
What this trial tests

trial testing CT scan for nose and paranasal sinuses in Antrochoanal Polyp in 80 participants. Completed in 30 August 2023.

Timeline
20 December 2022
Primary endpoint
30 July 2023
30 August 2023

Quick facts

Lead sponsorMinia University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date20 December 2022
Primary completion30 July 2023
Estimated completion30 August 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Eligibility, any sex, with Antrochoanal Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about anatomical and pathological variants in patients with antrochoanal polyps trying to find a key to its pathogenesis Participants will have nasal endoscopic examination and CT nose and paranasal sinuses. we will compare patients with antrochoanal polyps and other patients with unilateral sinonasal disease regarding anatomical and pathological variants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05989919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing